Literature DB >> 20981775

Autism spectrum features in Smith-Magenis syndrome.

Gonzalo Laje1, Rebecca Morse, William Richter, Jonathan Ball, Maryland Pao, Ann C M Smith.   

Abstract

Smith-Magenis syndrome (SMS; OMIM 182290) is a neurodevelopmental disorder characterized by a well-defined pattern of anomalies. The majority of cases are due to a common deletion in chromosome 17p11.2 that includes the RAI1 gene. In children with SMS, autistic-like behaviors and symptoms start to emerge around 18 months of age. This study included 26 individuals (15 females and 11 males), with a confirmed deletion (del 17p11.2). Parents/caregivers were asked to complete the Social Responsiveness Scale (SRS) and the Social Communication Questionnaire (SCQ) both current and lifetime versions. The results suggest that 90% of the sample had SRS scores consistent with autism spectrum disorders. Moreover, females showed more impairment in total T-scores (P = 0.02), in the social cognition (P = 0.01) and autistic mannerisms (P = 0.002) subscales. The SCQ scores are consistent to show that a majority of individuals may meet criteria for autism spectrum disorders at some point in their lifetime. These results suggest that SMS needs to be considered in the differential diagnosis of autism spectrum disorders but also that therapeutic interventions for autism are likely to benefit individuals with SMS. The mechanisms by which the deletion of RAI1 and contiguous genes cause psychopathology remain unknown but they provide a solid starting point for further studies of gene-brain-behavior interactions in SMS and autism spectrum disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981775      PMCID: PMC2967410          DOI: 10.1002/ajmg.c.30275

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  19 in total

1.  Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial.

Authors:  Barry Wright; David Sims; Siobhan Smart; Ahmed Alwazeer; Ben Alderson-Day; Victoria Allgar; Clare Whitton; Heather Tomlinson; Sophie Bennett; Jenni Jardine; Nicola McCaffrey; Charlotte Leyland; Christine Jakeman; Jeremy Miles
Journal:  J Autism Dev Disord       Date:  2011-02

2.  Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

Authors:  H De Leersnyder; J L Bresson; M-C de Blois; J-C Souberbielle; A Mogenet; B Delhotal-Landes; F Salefranque; A Munnich
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

3.  Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome.

Authors:  E M Dykens; A C Smith
Journal:  J Intellect Disabil Res       Date:  1998-12

4.  Brief report: cognitive and behavioral profiles in persons with Smith-Magenis syndrome.

Authors:  E M Dykens; B M Finucane; C Gayley
Journal:  J Autism Dev Disord       Date:  1997-04

5.  The spasmodic upper-body squeeze: a characteristic behavior in Smith-Magenis syndrome.

Authors:  B M Finucane; D Konar; B Haas-Givler; M B Kurtz; C I Scott
Journal:  Dev Med Child Neurol       Date:  1994-01       Impact factor: 5.449

6.  The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

Authors:  Juthamas Wirojanan; Sebastien Jacquemont; Rafael Diaz; Susan Bacalman; Thomas F Anders; Randi J Hagerman; Beth L Goodlin-Jones
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

7.  Sleep in children with autism spectrum disorders.

Authors:  Kyle P Johnson; Beth A Malow
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

8.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS).

Authors:  E Schopler; R J Reichler; R F DeVellis; K Daly
Journal:  J Autism Dev Disord       Date:  1980-03

9.  Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).

Authors:  A C Smith; E Dykens; F Greenberg
Journal:  Am J Med Genet       Date:  1998-03-28

10.  Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.

Authors:  Pamela L Wolters; Andrea L Gropman; Staci C Martin; Michaele R Smith; Hanna L Hildenbrand; Carmen C Brewer; Ann C M Smith
Journal:  Pediatr Neurol       Date:  2009-10       Impact factor: 3.372

View more
  34 in total

Review 1.  Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes.

Authors:  Juanita Neira-Fresneda; Lorraine Potocki
Journal:  J Pediatr Genet       Date:  2015-09-28

2.  The Broader Autism Phenotype and Visual Perception in Children.

Authors:  Antoinette Sabatino DiCriscio; Vanessa Troiani
Journal:  J Autism Dev Disord       Date:  2018-08

Review 3.  Epilepsy and Autism.

Authors:  Ashura W Buckley; Gregory L Holmes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

4.  Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.

Authors:  Ann C M Smith; Rebecca S Morse; Wendy Introne; Wallace C Duncan
Journal:  Am J Med Genet A       Date:  2019-02       Impact factor: 2.802

5.  Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome.

Authors:  Gonzalo Laje; Rebecca Bernert; Rebecca Morse; Maryland Pao; Ann C M Smith
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-11-15       Impact factor: 3.908

6.  Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways.

Authors:  Anthony J Griswold; Deqiong Ma; Holly N Cukier; Laura D Nations; Mike A Schmidt; Ren-Hua Chung; James M Jaworski; Daria Salyakina; Ioanna Konidari; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Scott M Williams; Ramkumar Menon; Eden R Martin; Jonathan L Haines; John R Gilbert; Michael L Cuccaro; Margaret A Pericak-Vance
Journal:  Hum Mol Genet       Date:  2012-04-27       Impact factor: 6.150

7.  Auditory Phenotype of Smith-Magenis Syndrome.

Authors:  Megan A Brendal; Kelly A King; Christopher K Zalewski; Brenda M Finucane; Wendy Introne; Carmen C Brewer; Ann C M Smith
Journal:  J Speech Lang Hear Res       Date:  2017-04-14       Impact factor: 2.297

Review 8.  Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era.

Authors:  Yong-Hui Jiang; Yi Wang; Xu Xiu; Kwong Wai Choy; Amber Nolen Pursley; Sau W Cheung
Journal:  Crit Rev Clin Lab Sci       Date:  2014-05-30       Impact factor: 6.250

Review 9.  Genomics and autism spectrum disorder.

Authors:  Norah L Johnson; Ellen Giarelli; Celine Lewis; Catherine E Rice
Journal:  J Nurs Scholarsh       Date:  2013-01-31       Impact factor: 3.176

10.  Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials.

Authors:  Charlotte DiStefano; Rujuta B Wilson; Carly Hyde; Edwin H Cook; Ronald L Thibert; Lawrence T Reiter; Vanessa Vogel-Farley; Joerg Hipp; Shafali Jeste
Journal:  Am J Med Genet A       Date:  2019-10-26       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.